Skip to main content
. 2013 Apr 15;5(2):430–461. doi: 10.3390/cancers5020430

Table 2.

List of commonly used HDAC inhibitors.

Chemical class HDAC inhibitor Reported targets
Benzamides SNDX-275 (MS-275, Entinostat) HDAC-1,-2,-3
CI-994 (Tacedinaline) HDAC-1, -2
MGCD-0103 HDAC-1, -2, -3, 11
Short Chain Fatty Acids Valproic acid (VPA) Class I and IIa
Sodium butyrate Class I and IIa, IV
Phenyl butyrate (S-HDAC-42, AR-42) Class I, II
Cyclic Peptides Depsipeptide (Romidepsin) HDAC -1, -2
Apicidin Class I
Hydroxamic Acids JNJ-26481585 Class I and II, IV
Suberoylanilide hydroxamic acid (SAHA; Vorinostat) Class I and II, IV
Trichostatin-A (TSA) Class I and II, IV
LBH589 (Panobinostat) Class I and II, IV
ITF2357 (Gavinostat) Class I and II
PXD101 (Belinostat) Class I and II, IV
NVP-LAQ824 (Dacinostat) Class I
Suberoylanilide bis-hydroxamic acid (SBHA) HDAC-1, -3
RAS2410 (Resminostat) HDAC-1, -3, -6
ACY-1215 (Rocilinostat) HDAC-6
CR-2408 Class I, II, IV
Mercaptoketone KD5170 Class I and II
Others Tubacin HDAC-6